Legend Capital logo

Legend Capital

Asia, Beijing, China, Beijing

Description

Legend Capital, established in 2001, stands as a preeminent venture capital firm based in Beijing, China, operating as a crucial subsidiary of Legend Holdings Ltd., the parent company renowned for founding Lenovo. The firm has successfully cemented its position as one of China's leading multi-stage investment entities, primarily concentrating on early-stage and growth-stage opportunities across various high-potential sectors. Its overarching mission is deeply aligned with fostering innovation and propelling the growth of enterprises within China's dynamic technology and healthcare ecosystems.

Legend Capital's investment strategy, while broadly sector-agnostic, has historically demonstrated a pronounced focus on high-growth industries. These include Technology, Media, and Telecommunications (TMT), Healthcare, Advanced Manufacturing, and Consumer sectors. The firm is widely recognized for its hands-on approach, extending beyond mere capital provision to offer strategic guidance and operational support to its diverse portfolio companies. They exhibit significant flexibility in their investment horizon, deploying capital across various stages, from early-growth rounds (typically Series A/B) to more mature growth-stage financings (Series C and beyond).

The firm manages a substantial pool of both USD and RMB-denominated funds, with its total assets under management (AUM) reportedly exceeding 50 billion RMB, which translates to approximately $7 billion USD, depending on the prevailing exchange rate. Since its inception, Legend Capital has made over 600 investments, showcasing its extensive reach and active participation in shaping the Chinese startup landscape. Their impressive track record includes over 100 successful IPOs and more than 100 M&A exits, underscoring their consistent ability to identify, nurture, and guide high-potential companies to successful liquidity events. For initial investments, the firm typically targets cheques ranging from approximately $5 million for early-growth stage companies to upwards of $50 million for more mature, high-potential ventures.

Investor Profile

Legend Capital has backed more than 103 startups, with 23 new investments in the last 12 months alone. The firm has led 26 rounds, about 25% of its total and boasts 48 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in China, United States, South Korea.
  • Strong thematic focus on Health Care, Medical, Manufacturing.
  • Led 6 rounds in the past year.
  • Typical check size: $5M – $50M.

Stage Focus

  • Series B (30%)
  • Series C (28%)
  • Series A (17%)
  • Series Unknown (8%)
  • Series D (7%)
  • Series E (5%)
  • Seed (3%)
  • Angel (2%)

Country Focus

  • China (72%)
  • United States (20%)
  • South Korea (4%)
  • Hong Kong (1%)
  • Indonesia (1%)
  • Japan (1%)

Industry Focus

  • Health Care
  • Medical
  • Manufacturing
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Medical Device
  • Information Technology
  • Software
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Legend Capital frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 6
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 7
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 6
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 7
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 7
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 5
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 11
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 9
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 5
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 4

Which angels does Legend Capital often collaborate with?

JE
North America, California, United States, San Francisco
Shared Deals: 1
Bo Shen
Asia, Shanghai, China, Jingan
Shared Deals: 1
OD
Europe, England, United Kingdom, London
Shared Deals: 1
Robin Li
Asia, Beijing, China
Shared Deals: 1

What are some of recent deals done by Legend Capital?

Chuangrui Spectrum

Dalian Shi, Liaoning, China

Chuangrui Spectrum is a manufacturer of precision spectroscopic instruments and semiconductor testing equipment.

ManufacturingProduct ResearchSemiconductor
Series AMar 18, 2026
Amount Raised: $14,549,899
Zhijian Power

Hangzhou, Zhejiang, China

Zhijian Power is a high-tech enterprise specializing in the research and development of intelligent driving technology.

Artificial Intelligence (AI)AutomotiveSaaS
Series AMar 9, 2026
Shenluo Medical

Hangzhou, Zhejiang, China

Shenluo Medical manufactures functional neural implantable medical devices.

Health CareManufacturing
Series CMar 4, 2026
Manifold AI

Chaoyang, Liaoning, China

Manifold AI is an artificial intelligence company that provides development of embodied intelligent world models.

Artificial Intelligence (AI)Robotics
SeedMar 4, 2026
Amount Raised: $28,910,090
VITURE

San Francisco, California, United States

VITURE is a 2C technology company dedicated to developing AR technology, creating trendy XR glasses.

Augmented RealityElectronicsManufacturingProduct Design
Series UnknownFeb 26, 2026
Amount Raised: $100,000,000

DreamTech is an AI startup company focusing on native 3D generation.

SeedFeb 14, 2026
Zhiran Medical

Beijing, Beijing, China

Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders.

Health CareMedicalNeuroscience
Series AFeb 11, 2026
Amount Raised: $43,397,127
Huixin Bio

Shenzhen, Guangdong, China

Huixin Bio is a developer of exosome purification products and early cancer detection technology.

BiopharmaBiotechnologyPharmaceutical
Series AFeb 9, 2026
Amount Raised: $14,440,642
Angitia Biopharmaceuticals

Westlake Village, California, United States

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

BiopharmaBiotechnologyHealth CareMedical
Series DFeb 5, 2026
Amount Raised: $130,000,000
Guoke Ion

Haidian, Beijing, China

Guoke Ion is an innovative enterprise focusing on the integration of advanced medical technology and financial services.

Series AFeb 2, 2026
Amount Raised: $115,214,010

Find More Investors Like Legend Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides